BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 33375253)

  • 1. Pregnancy-Induced High Plasma Levels of Soluble Endoglin in Mice Lead to Preeclampsia Symptoms and Placental Abnormalities.
    Pérez-Roque L; Núñez-Gómez E; Rodríguez-Barbero A; Bernabéu C; López-Novoa JM; Pericacho M
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat.
    Barrientos G; Pussetto M; Rose M; Staff AC; Blois SM; Toblli JE
    Mol Hum Reprod; 2017 Jul; 23(7):509-519. PubMed ID: 28402512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxysterol-induced soluble endoglin release and its involvement in hypertension.
    Valbuena-Diez AC; Blanco FJ; Oujo B; Langa C; Gonzalez-Nuñez M; Llano E; Pendas AM; Díaz M; Castrillo A; Lopez-Novoa JM; Bernabeu C
    Circulation; 2012 Nov; 126(22):2612-24. PubMed ID: 23110859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of soluble endoglin in the maternal circulation are associated with maternal vascular malperfusion lesions in the placenta of women with preeclampsia.
    Schmella MJ; Assibey-Mensah V; Parks WT; Roberts JM; Jeyabalan A; Hubel CA; Catov JM
    Placenta; 2019 Mar; 78():29-35. PubMed ID: 30955708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.
    Wang K; Ahmad S; Cai M; Rennie J; Fujisawa T; Crispi F; Baily J; Miller MR; Cudmore M; Hadoke PW; Wang R; Gratacós E; Buhimschi IA; Buhimschi CS; Ahmed A
    Circulation; 2013 Jun; 127(25):2514-22. PubMed ID: 23704251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Role of Circulating Endoglin in Hypertension via the Upregulated Expression of BMP4.
    Gallardo-Vara E; Gamella-Pozuelo L; Perez-Roque L; Bartha JL; Garcia-Palmero I; Casal JI; López-Novoa JM; Pericacho M; Bernabeu C
    Cells; 2020 Apr; 9(4):. PubMed ID: 32316263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trophoblast-Specific Expression of Hif-1α Results in Preeclampsia-Like Symptoms and Fetal Growth Restriction.
    Albers RE; Kaufman MR; Natale BV; Keoni C; Kulkarni-Datar K; Min S; Williams CR; Natale DRC; Brown TL
    Sci Rep; 2019 Feb; 9(1):2742. PubMed ID: 30808910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
    Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A
    Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFI16 mediates soluble Flt-1 and endoglin production by trophoblast cells.
    Li N; Fu Y; Chen W; Hu GQ; Zhou M; Yu SX; Zhang XJ; Du CT; Yang YJ
    J Hypertens; 2015 Aug; 33(8):1658-65. PubMed ID: 26002845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the mechanism for poor placentation in early-onset preeclampsia: the role of autophagy in trophoblast invasion and vascular remodeling.
    Saito S; Nakashima A
    J Reprod Immunol; 2014 Mar; 101-102():80-88. PubMed ID: 23969229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired autophagy by soluble endoglin, under physiological hypoxia in early pregnant period, is involved in poor placentation in preeclampsia.
    Nakashima A; Yamanaka-Tatematsu M; Fujita N; Koizumi K; Shima T; Yoshida T; Nikaido T; Okamoto A; Yoshimori T; Saito S
    Autophagy; 2013 Mar; 9(3):303-16. PubMed ID: 23321791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
    Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
    J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells.
    Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T
    Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress-induced Gadd45α inhibits trophoblast invasion and increases sFlt1/sEng secretions via p38 MAPK involving in the pathology of pre-eclampsia.
    Liu X; Deng Q; Luo X; Chen Y; Shan N; Qi H
    J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3776-85. PubMed ID: 26809169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms and therapeutic implications of the carbon monoxide/hmox1 and the hydrogen sulfide/CSE pathways in the prevention of pre-eclampsia and fetal growth restriction.
    Ahmed A
    Pregnancy Hypertens; 2014 Jul; 4(3):243-4. PubMed ID: 26104642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction.
    Brownfoot FC; Hannan NJ; Cannon P; Nguyen V; Hastie R; Parry LJ; Senadheera S; Tuohey L; Tong S; Kaitu'u-Lino TJ
    EBioMedicine; 2019 Mar; 41():636-648. PubMed ID: 30824385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction.
    Onda K; Tong S; Beard S; Binder N; Muto M; Senadheera SN; Parry L; Dilworth M; Renshall L; Brownfoot F; Hastie R; Tuohey L; Palmer K; Hirano T; Ikawa M; Kaitu'u-Lino T; Hannan NJ
    Hypertension; 2017 Mar; 69(3):457-468. PubMed ID: 28115513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP-14 aggravates onset of severe preeclampsia by mediating soluble endoglin release.
    Zhang XH; Zhang HY; Lu S; Jiang LL; Wu J; Yang YL; Zhang SA
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1209-1215. PubMed ID: 29565476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.